Hadean Ventures

Hadean Ventures is an Oslo, Norway-based venture capital firm that invests in early-stage life science, biotech, and healthcare companies across Europe, with a particular focus on underserved regions like the Nordics. The firm provides capital to startups developing products in pharmaceuticals, medical technology, diagnostics, and digital health. Hadean Ventures has raised $17.54 million for its own operations and manages venture capital funds, notably Hadean Capital I, which targeted €100 million, and Hadean Capital II, which successfully closed in December 2023. The firm's leadership includes Managing Partner Ingrid Teigland Akay, Principal Georgina Askeland, and Head of Investor Relations Ingrid Beyer. Institutional investors such as Argentum, Saminvest, and Gjensidigestiftelsen have committed capital to their funds. Hadean Ventures was founded in 2014.